NCT03431246

Immunogenicity of One Dose of Gardasil and One Dose of Gardasil-9

Persistance of Anti-HPV After a Single Dose of Gardasil and the Effect of a Dose of Gardasil-9 When Administered 3-8 Years Later

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 32 (actual)
• Sponsor: Laval University · Academic / Other
• Sex: Female
• Age: 12 Years – 18 Years
• Healthy volunteers: Accepted

Summary

This study will assess the immunogenicity of one dose of Gardasil and one dose of Gardasil-9

Detailed description

This is a one group exploratory study. The main objective of this study is to assess the persistance of anti-HPV after a single dose Gardasil and the effect of one dose of Gardasil-9 when administered 3-8 years later.

Conditions

• Human Papillomavirus Vaccines

Interventions

Type	Name	Description
BIOLOGICAL	Gardasil and Gardasil-9	All subjects will receive one dose of Gardasil-9. Blodd samples for serological testing will be collected just before and one month post Gardasil-9 administration.

Timeline

• Start date: 2016-10-01
• Primary completion: 2016-11-05
• Completion: 2016-12-05
• First posted: 2018-02-13
• Last updated: 2018-02-13

Locations

1 site across 1 country: Canada